First Horizon Advisors, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$74,117
-42.3%
2,344
-25.6%
0.00%
-25.0%
Q2 2023$128,456
+2.9%
3,150
-6.0%
0.00%0.0%
Q1 2023$124,854
+6.7%
3,350
-0.1%
0.00%0.0%
Q4 2022$117,055
-36.0%
3,355
+2.4%
0.00%
-42.9%
Q3 2022$183,000
+1.1%
3,275
-6.7%
0.01%
+16.7%
Q2 2022$181,000
+16.8%
3,511
+164.6%
0.01%
+20.0%
Q4 2021$155,000
-4.9%
1,327
+8.7%
0.01%0.0%
Q3 2021$163,000
+1.9%
1,221
+22.5%
0.01%
-44.4%
Q2 2021$160,000
+97.5%
997
-2.2%
0.01%
+80.0%
Q1 2021$81,0001,0190.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders